Shari Annes | IR |
Rachel King | President, CEO & Director |
Brian Hahn | SVP, CFO & Secretary |
Helen Thackray | SVP, Clinical Development & Chief Medical Officer |
Edward White | H.C. Wainwright & Co. |
Irina Margine | Cowen and Company |
Biren Amin | Jefferies |
Good morning, and thank you all for joining GlycoMimetics First Quarter 2019 Conference Call. [Operator Instructions]. I would now like to turn the call over to Sheri Annes of Investor Relations Group at GlycoMimetics. Please go ahead.
Good morning.